Fig. (1) Kaplan-Meier curves of overall survival in patients with advanced lung cancer, dependent on the status of (A) ECOG performance status, (B) Presence or absence of EGFR mutations or ALK fusions, (C) Serum CYFRA21-1, and (D) Serum CEA.

Back to Article